FDA Inspection 1176467 — Grifols Therapeutics LLC
The FDA completed an inspection of Grifols Therapeutics LLC on May 6, 2022 in Clayton, NC. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- May 6, 2022
- Fiscal Year
- 2022
- Product Type
- Biologics
- Project Area
- Vaccines and Allergenic Products
- Location
- Clayton, NC (United States)